data on non-small cell lung cancer. Could it be for one of the DYAX technology licensed antibodies?? A nice high single digit royalty, WW sales of a few $B, yes I can see it now, you can have my DYAX shares for $20.
Theres speculation just nothin to sink our teeth into yet or is there... ;>)
Lets see what comes out of ASCO